Cannabinoid signaling in glial cells (Q35897353)

11 August 2017

1 reference

title

Cannabinoid signaling in glial cells (English)

1 reference

11 August 2017

0 references

1 reference

Nephi Stella

1

1 reference

11 August 2017

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

48

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

267-277

1 reference

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

The palmitoylethanolamide family: a new class of anti-inflammatory agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Bradykinin Stimulates Arachidonic Acid Release Through the Sequential Actions of an sn-1 Diacylglycerol Lipase and a Monoacylglycerol Lipase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids enhance human B-cell growth at low nanomolar concentrations

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endogenous lipids that activate cannabinoid receptors. Formation and inactivation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Methylene blue blocks cGMP production and disrupts directed migration of microglia to nerve lesions in the leech CNS

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Evidence against the presence of an anandamide transporter

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Internalization and Recycling of the CB1 Cannabinoid Receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Regulation of cell motility by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Retrograde signaling by endocannabinoids

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Further evidence for the existence of a specific process for the membrane transport of anandamide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

An analgesia circuit activated by cannabinoids

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Increased severity of stroke in CB1 cannabinoid receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

DNA microarray analysis of cannabinoid signaling in mouse brain in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The endocannabinoid system as a target for therapeutic drugs.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide and other N-acylethanolamines in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Receptor-dependent formation of endogenous cannabinoids in cortical neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Reduced glial fibrillary acidic protein and glutamine synthetase expression in astrocytes and Bergmann glial cells in the rat cerebellum caused by delta(9)-tetrahydrocannabinol administration during development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Constituents of Cannabis sativa L. XVII. A review of the natural constituents

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Pain modulation by release of the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Cannabinoids and neuroinflammation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Astrocytes in culture produce anandamide and other acylethanolamides.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

P2X7 receptors control 2-arachidonoylglycerol production by microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20084

7 January 2021

Identifiers

DOI

10.1002/GLIA.20084

1 reference

11 August 2017

1 reference